ATOSSA THERAPEUTICS, INC. — Director's Dealing 2014

Apr 3, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ATOSSA GENETICS INC (ATOS)
CIK: 0001488039
Period of Report: 2014-04-01

Reporting Person: Chen Ben R (Sr. VP of Glob. Reg. Affairs)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-04-01	Stock Option (right to buy)	$1.69	A	300000	Acquired	2024-04-01	Common Stock (300000)	Direct

Footnotes

F1: The option shall vest with respect to one-quarter of the underlying shares on the first anniversary of the grant date and then vest with respect to 1/16th of the underlying shares quarterly thereafter so that the option is fully vested and exercisable on the fourth anniversary of the grant date.